Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stromal Cell Product (RegStem)

Clinical trial NCT03007576 · COMPLETED

Trial details

NCT number: NCT03007576
Sponsor: EMO Biomedicine Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Osteoarthritis,Knee

Start date: 2017-08-01
Primary completion: 2019-08-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.